Current Ratio of Inhibitor Therapeutics, Inc. from 30 Jun 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Inhibitor Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2014 to 30 Sep 2025.
  • Inhibitor Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 1649%, a 51% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Inhibitor Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 1649% -1722% -51% 30 Sep 2025
Q2 2025 2063% -1247% -38% 30 Jun 2025
Q1 2025 2684% -890% -25% 31 Mar 2025
Q4 2024 2867% -1323% -32% 31 Dec 2024
Q3 2024 3370% -1076% -24% 30 Sep 2024
Q2 2024 3309% +1561% +89% 30 Jun 2024
Q1 2024 3575% +2751% +334% 31 Mar 2024
Q4 2023 4190% +3846% +1119% 31 Dec 2023
Q3 2023 4446% +4440% +70795% 30 Sep 2023
Q2 2023 1749% +1741% +21262% 30 Jun 2023
Q1 2023 824% +812% +6399% 31 Mar 2023
Q4 2022 344% +326% +1857% 31 Dec 2022
Q3 2022 6.3% -16% -72% 30 Sep 2022
Q2 2022 8.2% -15% -64% 30 Jun 2022
Q1 2022 13% -14% -53% 31 Mar 2022
Q4 2021 18% -24% -58% 31 Dec 2021
Q3 2021 22% -63% -74% 30 Sep 2021
Q2 2021 23% -152% -87% 30 Jun 2021
Q1 2021 27% -298% -92% 31 Mar 2021
Q4 2020 42% -346% -89% 31 Dec 2020
Q3 2020 85% -259% -75% 30 Sep 2020
Q2 2020 175% -151% -46% 30 Jun 2020
Q1 2020 325% +72% +28% 31 Mar 2020
Q4 2019 388% +116% +43% 31 Dec 2019
Q3 2019 344% +83% +32% 30 Sep 2019
Q2 2019 326% +53% +19% 30 Jun 2019
Q1 2019 253% -93% -27% 31 Mar 2019
Q4 2018 272% -132% -33% 31 Dec 2018
Q3 2018 261% -739% -74% 30 Sep 2018
Q2 2018 274% -743% -73% 30 Jun 2018
Q1 2018 346% -665% -66% 31 Mar 2018
Q4 2017 404% -327% -45% 31 Dec 2017
Q3 2017 1000% +604% +152% 30 Sep 2017
Q2 2017 1017% +730% +255% 30 Jun 2017
Q1 2017 1011% +824% +439% 31 Mar 2017
Q4 2016 731% +530% +262% 31 Dec 2016
Q3 2016 396% +197% +99% 30 Sep 2016
Q2 2016 286% +124% +76% 30 Jun 2016
Q1 2016 187% +117% +165% 31 Mar 2016
Q4 2015 202% +149% +281% 31 Dec 2015
Q3 2015 199% +171% +605% 30 Sep 2015
Q2 2015 163% +151% +1295% 30 Jun 2015
Q1 2015 71% 31 Mar 2015
Q4 2014 53% 31 Dec 2014
Q3 2014 28% 30 Sep 2014
Q2 2014 12% 30 Jun 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.